How Growth-Hormone Secretagogues Actually Work
CJC-1295, Ipamorelin, and the biology behind why they're almost always stacked together, not run alone.
Growth hormone isn't released continuously — it comes out in pulses, mostly during deep sleep, driven by two separate signals arriving at the pituitary gland from different directions. Understanding those two signals is the entire reason CJC-1295 and Ipamorelin get paired instead of used individually.
CJC-1295 is a GHRH (growth-hormone-releasing hormone) analog. It mimics the hypothalamus's own "release GH now" signal, extending how long that signal stays active in the bloodstream compared to natural GHRH, which is cleared in minutes. On its own, it raises the size of a GH pulse that's already happening — it doesn't create a pulse out of nothing.
Ipamorelin works on a completely different receptor — the ghrelin receptor (GHS-R) — mimicking ghrelin's GH-releasing effect without meaningfully touching appetite or cortisol the way older secretagogues in its class (like GHRP-6) are known to. It acts more like a trigger, prompting a pulse to happen, while suppressing somatostatin, the hormone that would otherwise blunt the pulse.
Stacked together, the logic is additive rather than redundant: CJC-1295 raises the ceiling of a pulse, Ipamorelin makes the pulse more likely to fire and fire cleanly. That's the actual mechanistic reason the community near-universally runs them together rather than choosing one — it isn't just convention for its own sake.
It's also why timing matters more for this class than for most other compounds on this site: dosing is centered on bedtime specifically because it rides the same window as the body's largest natural GH pulse, rather than fighting against it.